Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Market Cap	1.81B
Revenue (ttm)	232.20M
Net Income (ttm)	9.92M
Shares Out	2.40M
EPS (ttm)	4.13
PE Ratio	182.61
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Dec 3, 2024

Volume	5,401
Average Volume	1,481
Open	769.00
Previous Close	748.20
Day's Range	730.00 - 799.90
52-Week Range	650.00 - 1,002.70
Beta	-0.20
RSI	68.46
Earnings Date	Jan 27, 2025

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid dr...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 529
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2024, Ambee Pharmaceuticals's revenue was 219.30 million, an increase of 10.71% compared to the previous year's 198.10 million. Earnings were 9.68 million, an increase of 6.53%.